|
Name |
Oleoyl chloride
|
Molecular Formula | C18H33ClO | |
IUPAC Name* |
(Z)-octadec-9-enoyl chloride
|
|
SMILES |
CCCCCCCC/C=C\CCCCCCCC(=O)Cl
|
|
InChI |
InChI=1S/C18H33ClO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3/b10-9-
|
|
InChIKey |
MLQBTMWHIOYKKC-KTKRTIGZSA-N
|
|
Synonyms |
Oleoyl chloride; Oleic acid chloride; 112-77-6; (Z)-octadec-9-enoyl chloride; 9-Octadecenoyl chloride, (Z)-; Oleic chloride; oleoylchloride; U83VP176UX; 9-Octadecenoyl chloride, (9Z)-; NSC-97299; UNII-U83VP176UX; (Z)-9-Octadecenoyl chloride; EINECS 204-005-0; MFCD00134332; NSC 97299; EC 204-005-0; Oleoyl chloride, >=89%; cis-9-octadecenoyl chloride; SCHEMBL284449; (9Z)-9-Octadecenoyl chloride; 9-Octadecenoylchloride,(9Z)-; (9Z)-octadec-9-enoyl chloride; DTXSID70893143; (9Z)-9-Octadecenoyl chloride #; Oleoyl chloride, >=99% (GC); NSC97299; STR06905; AKOS024386324; ZINC100006588; DB14666; 9-(Z)-OCTADECEN-1-OYL CHLORIDE; CS-0185582; O0053; F20352; A802649; J-002834; Q27290815
|
|
CAS | 112-77-6 | |
PubChem CID | 5364783 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 300.9 | ALogp: | 8.3 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 20 | QED Weighted: | 0.186 |
Caco-2 Permeability: | -4.78 | MDCK Permeability: | 0.00001690 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.015 | 20% Bioavailability (F20%): | 0.996 |
30% Bioavailability (F30%): | 0.986 |
Blood-Brain-Barrier Penetration (BBB): | 0.293 | Plasma Protein Binding (PPB): | 98.96% |
Volume Distribution (VD): | 3.026 | Fu: | 1.04% |
CYP1A2-inhibitor: | 0.312 | CYP1A2-substrate: | 0.209 |
CYP2C19-inhibitor: | 0.417 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.235 | CYP2C9-substrate: | 0.967 |
CYP2D6-inhibitor: | 0.137 | CYP2D6-substrate: | 0.589 |
CYP3A4-inhibitor: | 0.376 | CYP3A4-substrate: | 0.079 |
Clearance (CL): | 4.524 | Half-life (T1/2): | 0.773 |
hERG Blockers: | 0.324 | Human Hepatotoxicity (H-HT): | 0.163 |
Drug-inuced Liver Injury (DILI): | 0.317 | AMES Toxicity: | 0.966 |
Rat Oral Acute Toxicity: | 0.041 | Maximum Recommended Daily Dose: | 0.039 |
Skin Sensitization: | 0.968 | Carcinogencity: | 0.716 |
Eye Corrosion: | 0.989 | Eye Irritation: | 0.982 |
Respiratory Toxicity: | 0.971 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001591 | 0.839 | D0O1PH | 0.732 | ||||
ENC001419 | 0.839 | D0O1TC | 0.538 | ||||
ENC001602 | 0.839 | D07ILQ | 0.519 | ||||
ENC001100 | 0.839 | D0OR6A | 0.468 | ||||
ENC001555 | 0.839 | D0UE9X | 0.462 | ||||
ENC001646 | 0.839 | D0Z5SM | 0.461 | ||||
ENC001592 | 0.839 | D05ATI | 0.444 | ||||
ENC001540 | 0.800 | D00AOJ | 0.393 | ||||
ENC001680 | 0.800 | D0Z5BC | 0.388 | ||||
ENC001688 | 0.800 | D00FGR | 0.375 |